mild side effects of Humira may include injection site reactions, such as: Studies show the most common long-term risks ...

Humira comes next with sales of $10.3 billion, followed by Gilead’s HIV drug Biktarvy ($10 bn), Pfizer’s breast cancer drug Ibrance ($9 billion), Johnson & Johnson’s Stelara for inflammatory ...

In the case of Humira, the phages were made to display ... counteract autoimmune diseases and cure metastatic cancer. CalTech’s Frances Arnold conducted the first directed evolution of enzymes ...

Effectiveness between the adalimumab biosimilars (Amjevita and Imraldi) and the original brand-name version (Humira) was comparable both in new users and for patients switching from the original ...